Foghorn Therapeutics Inc is a biotechnology company that specializes in the development of treatments for cancer and other genetic diseases by focusing on the modulation of gene expression

The company leverages its proprietary Gene Traffic Control platform to create small molecule therapies that specifically target the proteins involved in gene regulation, with the aim of providing more effective and personalized treatment options. By understanding and manipulating the underlying mechanisms of gene activity, Foghorn seeks to address unmet medical needs and improve patient outcomes in challenging therapeutic areas.